- Issuer ticker
-
INAB
- Reported as of
-
08 May 2025
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
12 May 2025, 16:15:11 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Jason Minio, Attorney-in-Fact
Key filing fact
Alan S. Roemer filed Form 4 for IN8BIO, INC. (INAB) on 12 May 2025.
Key facts
- This page summarizes Alan S. Roemer's Form 4 filing for IN8BIO, INC. (INAB).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 12 May 2025, 16:15.
Change
- Previous filing in this sequence was filed on 07 May 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001643070
Primary reporting owner
Roemer Alan S.
- Relationship
-
Director
- Address
- C/O IN8BIO, INC., 350 5TH AVE. SUITE 5330, NEW YORK
- Signature
- /s/ Jason Minio, Attorney-in-Fact
- Signature date
- 12 May 2025
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INAB
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +63,150
- Change %
- Price
-
$0.000000
- Shares after
- 63,150
- Date
- 08 May 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 63,150
- Exercise price
- $0.1700
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote